Elizabeth Rozek's Insider Trades & SAST Disclosures

Elizabeth Rozek's most recent trade in Sagimet Biosciences Inc - Ordinary Shares - Class A was a trade of 13,367 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Nov. 4, 2025.

Share

Note

This is a custom search result for pattern Elizabeth Rozek.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Sagimet Biosciences Inc (Class A) High Gain High Volume	Elizabeth Rozek	Chief Legal & Admin. Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	04 Nov 2025	13,367	13,367	-		-	Stock Option (Right to Buy)
Sagimet Biosciences Inc (Class A) High Gain High Volume	Elizabeth Rozek	Chief Legal & Admin. Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	04 Nov 2025	9,855	193,581	-		0	Series A Common Stock
Sagimet Biosciences Inc (Class A) High Gain High Volume	Elizabeth Rozek	General Counsel and CCO	Sale of securities on an exchange or to another person at price $ 9.13 per share.	21 Jul 2025	10,780	183,726	-	9.1	98,471	Series A Common Stock
Sagimet Biosciences Inc (Class A) High Gain High Volume	Elizabeth Rozek	General Counsel and CCO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	06 Feb 2025	138,000	138,000	-		-	Stock Option (Right to Buy)
Sagimet Biosciences Inc (Class A) High Gain High Volume	Elizabeth Rozek	General Counsel and CCO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	06 Feb 2025	34,000	194,506	-		0	Series A Common Stock
Sagimet Biosciences Inc (Class A) High Gain High Volume	Elizabeth Rozek	General Counsel and CCO	Sale of securities on an exchange or to another person at price $ 3.10 per share.	19 Jul 2024	10,914	160,506	-	3.1	33,830	Series A Common Stock
Sagimet Biosciences Inc (Class A) High Gain High Volume	Elizabeth Rozek	General Counsel and CCO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 Jul 2023	242,142	242,142	-		-	Stock Option (Right to Buy)
Sagimet Biosciences Inc (Class A) High Gain High Volume	Elizabeth Rozek	General Counsel and CCO	Sale or transfer of securities back to the company at price $ 0.00 per share.	18 Jul 2023	242,142	0	-		-	Stock Option (Right to Buy)

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades